Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
/PRNewswire/ -- Inmagene Biopharmaceuticals (Inmagene), a clinical-stage biotech company developing innovative and differentiated therapies for immunological...